103 Results (Page 1 of 9)
Germany Markets Research Reports
Germany Diabetes Devices Market Analysis
The Germany Diabetes Devices Market is expected to witness growth from $832 Mn in 2022 to $1267 Mn in 2030 with a CAGR of 5.40% for the forecasted year 2022-2030. The demand for diabetes devices is being driven by the high and rising incidence of diabetes in Germany. The market is segmented by type and by the end user. Some key players in this market include Rein Medical GmbH, KLS Martin, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
Germany Cardiac Surgery Instruments Market Analysis
The Germany Cardiac Surgery Instruments Market is expected to witness growth from $76 Mn in 2022 to $110 Mn in 2030 with a CAGR of 4.80% for the forecasted year 2022-2030. In Germany, coronary heart disease, heart failure, and atrial fibrillation are among the leading causes of morbidity and death. The demand for cardiac surgery equipment is anticipated to increase as these illnesses become more common in the German healthcare market. The market is segmented by type, application and by end user. Some key players in this market include KLS Martin, Aesculap AG, RZ Medizintechnik GmbH, LivaNova, B. Braun, Medline Industries and STILLE.
Germany Cardiovascular Diseases Therapeutics Market Analysis
Germany's cardiovascular disease therapeutics market is expected to witness growth from $5.95 Bn in 2022 to $9.08 Bn in 2030 with a CAGR of 5.42% for the year 2022-2030. Technological advancements and supportive government policies in terms of cardiovascular diseases in Germany are responsible for the growth of the market. The Germany cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Waypharm, Cordes Pharma, and Pfizer are the major players in the Germany cardiovascular disease therapeutics market.
Germany Healthcare Claims Management Market Analysis
The German healthcare claims management market is projected to grow from $977.22 Mn in 2022 to $4671.55 Mn by 2030, registering a CAGR of 21.6% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing healthcare expenditure, regulatory reforms, technological advancements and growing demand for outsourcing. The market is segmented by component, type, by delivery mode and end-user. Some of the major players include AOK Systems, CompuGroup Medical, McKesson, Cognizant and Optum.
Germany Artificial Intelligence (AI) in Healthcare Market Analysis
Germany's Artificial Intelligence (AI) in the healthcare market is projected to grow from $0.25 Bn in 2022 to $4.52 Bn by 2030, registering a CAGR of 43.42% during the forecast period of 2022-30. The market will be driven by the country's excellent research and development capabilities, well-established healthcare infrastructure, and favorable government policies. The market is segmented by healthcare components & by healthcare applications. Some of the major players include Google Health, NVIDIA Corporation, Semalytix & Smart Reporting.
Germany Healthcare Insurance Market Analysis
The German healthcare insurance market is projected to grow from $74.16 Bn in 2022 to $116.43 Bn by 2030, registering a CAGR of 5.8% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, technological advancements, rising healthcare costs and competition among insurers. The market is segmented by the component, provider, coverage, by health insurance plans and end-user. Some of the major players include HanseMerkur, Arag, Hallesche, SDK, uniVersa and Alte Oldenburger.
Germany Anti Aging Therapeutics Market Analysis
Germany anti-aging therapeutics market is projected to grow from $22 Mn in 2022 to $66 Mn in 2030 with a CAGR of 14.73% for the year 2022-2030. The major factors responsible for the expansion of the market are the increased demand for anti-aging treatment options as a result of the rising elderly population. The Germany anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the leading players in the market include CureVac, Rentschler Biopharma, and Advancells.
Germany ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Germany's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is expected to witness growth from $1.08 Bn in 2022 to $1.68 Bn in 2030 with a CAGR of 5.7% for the year 2022-30. The major market drivers include rising awareness of the disorder and the increasing supply of ADHD drugs which include both stimulants and non-stimulants. The Germany ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Some of the major competitors in the market are Adragos Pharma, Hermes Arzneimittel, and Shire.
Germany Oncology Clinical Trials Market Analysis
Germany's oncology clinical trials market is projected to grow from $463 Mn in 2022 to $619.2 Mn by 2030, registering a CAGR of 3.7% during the forecast period of 2022-30. The market will be driven by the strong healthcare infrastructure, focus on personalized medicine, and experienced workforce. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis AG, Roche Holding AG, Bayer AG & BioNTech SE.
Germany Oral Care Market Analysis
The Germany Oral Care market was valued at $1.29 Bn in 2022 and is estimated to expand at a CAGR of 4.4% from 2022 to 2030 and will reach $1.82 Bn in 2030. One of the main reasons propelling the growth of this market is introduction of newer technologies, Increasing prevalence of dental diseases. The market is segmented by type, drug and distribution channel. Some key players in this market are Elmex, Meridol, Dr. Best, Dontodent, blend-a-dent Biorepair, Odol-med3, Listerine, Kukident among others.
Germany Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Germany Liver Disease Therapeutics market will reach a value of $1148 Mn from $845 Mn in 2022, growing at a CAGR of 3.9% during 2022-2030. Liver Disease Therapeutics in Germany is dominated by a few domestic pharmaceutical companies such as Boehringer Ingelheim, Bayer, and BioNTech. The Liver Disease Therapeutics market in Germany is segmented into different types of disease and different therapy types. Some of the major factors affecting the German Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Germany Multiple Myeloma Therapeutics Market Analysis
The Germany Multiple Myeloma Therapeutics Market was valued at $305 Mn in 2022 and is estimated to expand at a CAGR of 2.7% from 2022 to 2030 and will reach $378 Mn in 2030. One of the main reasons propelling the growth of this Market is increase in chronic disease, Increasing adoption of combination therapies. The Market is segmented by type, drug and distribution channel. Some key players in this Market are Abbott, MorphoSys, Merck, Medigene, Affimed, Helios Hospital, Vivantes Hospital Group and others.
Germany Diabetes Drugs Market Analysis
The Germany diabetes drugs market size was valued at $2.26 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 4.3% from 2022 to 2030 and will reach $3.16 Bn in 2030. The market is segmented by drug type, application, and distribution channel. The Germany diabetes drug market will grow because there is a growing focus on preventive measures to reduce the risk of developing diabetes, including lifestyle changes, which is also driving the demand for diabetes management products and services. The key market players are Boehringer Ingelheim, Sanofi, Boehringer Ingelheim, Eli Lilly and Company and others.
Germany Alexipharmic Drugs Market Analysis
Germany's Alexipharmic drugs market size was valued at $xx Bn in 2022 and is estimated to expand at a CAGR of 2.90% from 2022-30 and will reach $xx Bn in 2030. The market is segmented by product type, indication, route of administration, end-user, and distribution channel. The Germany Alexipharmic Drugs market will grow because of growing awareness in Germany about the risks of poisoning and the importance of having quick access to antidotes in case of an emergency. The key market players are Merck KGaA (DEU), CSL Behring (DEU), Grifols Deutschland (DEU), Wockhardt GmbH (DEU), B. Braun Melsungen AG (DEU), and others.
Germany Robotic Surgery Services Market Analysis
Germany's robotic surgery service market size was valued at $157 Mn in 2022 and is estimated to expand at a CAGR of 17.5% from 2022-30 and will reach $570 Mn in 2030. The robotic surgery service market will grow due increasing availability of advanced medical technologies, such as sophisticated surgical robots and imaging systems. The market is segmented by product and service type, application type, and end user. Some of the major players are Richard Wolf GmbH, Medtronic GmbH, Stryker Corporation, Smith & Nephew, and others.
Germany Connected Healthcare Market Analysis
The Germany-connected healthcare market is projected to grow from $2.43 Bn in 2022 to $16.03 Bn by 2030, registering a CAGR of 26.6% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, strong healthcare infrastructure, research and development infrastructure and government support. The market is segmented by type, function and by application. Some of the major players include Siemens Healthineers, Fresenius Medical Care, CompuGroup Medical, Telekom Healthcare Solutions, Philips Healthcare, IBM, Medtronic, Apple and Honeywell.
Germany Artificial Intelligence (AI) in Medical Imaging Market Analysis
The Germany Artificial Intelligence (AI) in Medical Imaging market size was valued at $55 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 33.6% from 2022 to 2030 and will reach $557 Mn. The market is segmented by AI technology, solution, modality, application, and end User. The Germany Artificial Intelligence (AI) in the Medical Imaging market will grow due to advances in AI and machine learning algorithms that are making it possible to develop more accurate and efficient medical imaging software. Some of the key players in this market are Siemens Healthineers, Philips Healthcare, Agfa-Gevaert Group, Canon Medical Systems, Fujifilm, and others.
Germany Primary Hyperoxaluria (PH) Therapeutics Market Analysis
The Germany Primary Hyperoxaluria (PH) Therapeutics market was valued at $XX Bn in 2022 and is estimated to expand at a CAGR of 3% from 2022 to 2030 and will reach $XX Bn in 2030. One of the main reasons propelling the growth of this market is government support, aging population. The market is segmented by diagnostic method, by treatment, and by type. Some key players in this market include Sanofi S.A, Allena Pharmaceuticals, Inozyme Pharma, Evotec, Dicerna Pharmaceuticals, and Alnylam Pharmaceuticals, among others.
Germany Neurology Clinical Trials Market Analysis
The Germany Neurology Clinical Trials market is projected to grow from $191.4 Mn in 2022 to $256 Mn by 2030, registering a CAGR of 3.7% during the forecast period of 2022 - 2030. The market will be driven by the rising frequency of neurological illnesses such as Alzheimer's, Parkinson's, multiple sclerosis, and epilepsy and regulatory frameworks that encourage clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis, Pfizer & Bayer.
Germany 3D Printing Medical Devices Market Analysis
The Germany 3D Printing Medical Devices market size was valued at $109 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 14.5% from 2022 to 2030 and will reach $321 Mn in 2030. The market is segmented by component, application, technology, and end user. The Germany 3D printing medical devices market will grow as the 3D printing technology has made a significant impact in the medical industry by enabling the production of personalized and complex medical devices. The key market players are Some of the key players in the market include SLM Solutions Group AG, EOS GmbH, Concept Laser GmbH, Materialise NV, Stratasys Ltd, 3D Systems Corporation, and others.
Germany Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Analysis
The Germany COPD Therapeutics Market was valued at $668 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.3% from 2022 to 2030 and will reach $1010 Mn in 2030. One of the main reasons propelling the growth of this market is increase prevalence rate, government initiative. The market is segmented by Drug class and by distribution channel. Some key players in this market are Kaia Health, Grifols, Riemser, Adamis Pharmaceuticals Corporation, Almirall, Astellas Pharma, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Novartis, Pfizer, Teva Germany Limited and others.
Germany Teleradiology Market Analysis
The Germany Teleradiology market size was valued at $87 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.9% from 2022 to 2030 and will reach $ 185 Mn in 2030. The market is segmented by application, modality, technology solutions, and end user. The Germany teleradiology market will grow due to Increasing demand for remote radiology services. The key market players are Radiology Consultants Associated (RCA), NightHawk Radiology Services, Calgary Scientific, and others.
Germany Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the German infectious disease therapeutics market will reach a value of $5.37 Bn from $4.39 Bn in 2022, growing at a CAGR of 2.6% during 2022-2030. Infectious Disease Therapeutics in Germany is dominated by a few domestic pharmaceutical companies such as BioNTech, Evotec and InfectoPharm. The Infectious Disease Therapeutics market in Germany is segmented into different therapeutic areas and different diseases type. The major factors affecting the German infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the lack of healthcare funding for infectious disease treatment in various areas of Germany.
Germany Clinical Diagnostics Market Analysis
Germany's clinical diagnostic market was valued at $2.52 Bn in 2022 and is estimated to expand at a CAGR of 4.2% from 2022-30 and will reach $3.50 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and government support. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, Siemens AG, Hologic, Qiagen NV, Quest Diagnostics, F. Hoffmann-La Roche Ltd, Merck and others.
Germany Neurology Devices Market Analysis
Germany's neurology devices market size is at around $461.89 Mn in 2022 and is projected to reach $736.19 Mn in 2030, exhibiting a CAGR of 6% during the forecast period. The medical technology leader in manufacturing and engineering in Germany is home to several major market players in the neurological devices industry, including Medtronic, Boston Scientific, and St. Jude Medical, which are driving growth in the market. This report by Insights10 is segmented by product type like neurostimulation, interventional neurology, neurosurgery devices, and neuro-endoscopes, and by the end user.